Viatris Inc
NASDAQ:VTRS
Viatris Inc
Common Stock
Viatris Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
Common Stock
$12.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-27%
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Stock
$3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Stock
$292m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Pfizer Inc
NYSE:PFE
|
Common Stock
$480m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Common Stock
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Stock
$594.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Viatris Inc's Common Stock?
Common Stock
12.3m
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Common Stock amounts to 12.3m USD.
What is Viatris Inc's Common Stock growth rate?
Common Stock CAGR 10Y
-27%
Over the last year, the Common Stock growth was 2%. The average annual Common Stock growth rates for Viatris Inc have been 1% over the past three years , 15% over the past five years , and -27% over the past ten years .